glargine

Novo Nordisk today announced the headline results from SWITCH 1, the second of two 2x32-weeks randomised, double-blind, cross-over, treat-to-target trials, comparing the safety and efficacy of Tresiba ® (insulin degludec) and Lantus ® (insulin glargine U100). The overall purpose of the trial was...

Hi, I'm determined to get this disease controlled, 27 years since 1st diagnosis as gestational. Then it stuck with me. Sick of it in my life to be honest, but I know I can't do much about that, so am trying a different tactic. I went on Day 1 of the T1DE course last week, and am delighted with...